• KOL
  • Disease
  • Hematologic
  • Hematologic Malignancies
  • David Cohan
    • David Cohan

    David Cohan

    Hematologic Malignancies  |  Chronic Lymphocytic Leukemia |  Phase 2 Study |  Small Lymphocytic |  Duvelisib Patients

    Key People For Hematologic Malignancies

    Top KOLs in the world
    #1
    Hagop Meguerditch Kantarjian
    consultancy funding board directors advisory committees
    #2
    Frederick R Appelbaum
    marrow transplantation acute myeloid leukemia host disease
    #3
    Rainer F Rainer
    marrow transplantation host disease aplastic anemia
    #4
    Richard E Champlin
    stem cell bone marrow multiple myeloma
    #5
    Kenneth Carl Anderson
    multiple myeloma mm cells board directors
    #6
    Susan Mary O' Brien
    consultancy funding chronic lymphocytic leukemia board directors
    Select a search phrase   hematologic malignancies , hematologic malignancies review , hematologic malignancies risk , hematologic malignancies hm , hematologic malignancies hsct

    David Cohan:Expert Impact

    Concepts for whichDavid Cohanhas direct influence:Hematologic malignancies,  Chronic lymphocytic leukemia,  Phase 2 study,  Small lymphocytic,  Duvelisib patients,  Tyrosine kinase inhibitor,  Refractory cll.

    David Cohan:KOL impact

    Concepts related to the work of other authors for whichfor which David Cohan has influence:Decision analysis,  Wildlife management,  Risk concepts,  Wildfire hazard,  Recreational fishery,  Angler utility,  Domain criteria.

     

    Tools

    Is this your profile? manage_accounts Claim your profile content_copy Copy URL code Embed Link to your profile

search KOL Search
search KOL Search